Studies & Data
HA Reports Nov. 2011: Atrial Fibrillation Catheter Ablation v Surgical Ablation Treatment, a two-centred randomized clinical trial
Self-monitoring of oral anticoagulation: systematic review
and meta-analysis of individual patient data
From Coronary Care Unit to Acute Cardiac Care Unit – the evolving role of specialist cardiac care
Recommendations of the British Cardiovascular Society Working Group on Acute Cardiac Care.
View report
UK Heart Patients Among the Most Under-Treated in Europe, Reveals Major New Report
US: Emergency doctors call for the need for routine surveillance of new oral anticoagulants
US: Warfarin listed in top four for emergency hospitalisations
UK: NICE approve apixaban for DVT prevention
Abstract 16443: Development of a New Risk Stratification Scheme to Predict Warfarin-Associated Hemorrhage: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
GPs undertreating AF in stroke patients
Ethnic Differences in Anti-coagulation
ESC: Older Afib Patients Tolerate Anticoagulants
Medpage Today
In this prospective study, warfarin was administered to patients older than 80 who had atrial fibrillation. The rate of major bleeding was low, supporting the notion that advanced age is not a contradindication to warfarin therapy.
Penn Study Indicates Atrial Fibrillation May Be Root Cause of Some Severe Mitral Regurgitation Cases
First Study to Make the Connection Between Heart Rhythm Irregularities and Leaky Heart Valves.
ARISTOTLE: A major win for apixaban in AF
Theheart.org
Paris, France (updated) - The full results of the ARISTOTLE trial have certainly lived up to expectations, showing convincing benefits of the new oral factor Xa inhibitor apixaban (Eliquis, Pfizer/Bristol-Myers Squibb) over warfarin in atrial fibrillation (AF) patients.
Warfarin anti-clotting drug may be safe for elderly
Studies suggest warfarin anticoagulation treatment may be underused for over 80s with atrial fibrillation
Management of atrial fibrillation by primary care physicians in Germany
Baseline results of the ATRIUM registry
Proposal for new physiology-based AF classification is supported by AFNET and EHRA
Innovations in support
Business case studies which bring specialist support into general practice.
Read more on:
ECG interpretation in Primary Care
How Can We Avoid a Stroke Crisis in the Asia-Pacific Region?
Working Group Report: Stroke Prevention in Patients with Atrial Fibrillation
Apixaban as an alternative to aspirin in patients with AF:
New evidence: Connolly et al (N. Engl. J. Med 2011; 364:806-17) conducted a trial in 5599 patients with AF for whom anticoagulation with a vitamin K antagonist was considered unsuitable.
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Robert G. Hart, MD; Oscar Benavente, MD; Ruth McBride, BS; and Lesly A. Pearce, MS
Examples of Successful Pulse Screening
Models of pulse screening initiatives have been incorporated into regional clinical practices across England. These documents provide evidence relating to the implementation, effectiveness, cost and outcomes of using pulse checks to identify cardiac arrhythmias.
-
Atrial Fibrillation in Primary Care Surrey Heart and Stroke Network, Surrey PCT
-
Atrial Fibrillation (AF) Primary Care Diagnosis and Management Pathway
The cost of poor treatment of abnormal heart rhythm puts patients lives at risk
Source: Medical News Today
Efficacy and Safety of Dabigatran Compared With Warfarin at Different Levels of International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation: An Analysis of the RE-LY Trial
Wallentin L, Yusuf S, Ezekowitz MD, et al., on behalf of the RE-LY Investigators.
Lancet 2010;Aug 27:[Epub ahead of print].
Study Question: Does the time in therapeutic range (TTR) affect the efficacy of warfarin relative to dabigatran?
Read more
Stroke Prevention in AF, Avoiding a Stroke Crisis
Action for Stroke Prevention, an alliance of cardiologists, neurologists, family doctors and patient groups, have urged EU policymakers to improve stroke risk assessment and diagnosis of atrial fibrillation before the increasing frequency of strokes becomes "a major public health crisis.’’
Read more>>
NHS Stroke Improvement Programme: Atrial Fibrillation – Detection and Optimal Therapy in Primary Care
Paper reviewing opportunistic screening of pulse palpitation in patients over 65 years of age.Heart and Stroke Improvement
Commissioning for Stroke, Prevention in Primary Care -
The Role of Atrial Fibrillation
NHS Improvement
Prototype software currently for evaluation only.
‘The Auricle' is a new screening device currently being developed by NHS Innovations East which links to the CHADS2” risk calculator.
Click here to view
Atrial fibrillation—so what? Changing clinical practice
Michelle Bennett, BHF Arrhythmia Nurse Specialist, highlights clinical changes improving the management of Atrial Fibrillation. Published by kind permission from the British Journal of Cardiac Nursing.
Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter, a study to evaluate the feasibility and safety of a novel multielectrode catheter that delivers duty-cycled bipolar and unipolar radiofrequency (RF) energy.
Download article
Atrial Fibrillation, stroke risk and costs, Department of Health data November 2008.